Olive Diagnostics Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Jerusalem Israel

Primary Industry

Medical Devices & Equipment

About

Founded in 2019 by Guy Goldman (CEO), and Corey Katz, and based in Jerusalem, Israel, Olive Diagnostics Ltd. is a health tech startup that uses artificial intelligence (AI) and derives important health data by analyzing the urine of people. In August 2022, Olive Diagnostics Ltd. raised USD 7.3 million in Seed funding from Amgen Ventures, eHealth Ventures, Geberit International AG, Mayo Clinic Medical Center, Mekorot Water, and WellFleet Capital Partners, Inc. The firm has developed a medical device that works as a passive sensor called Olive KG mounted in toilets that measures the composition of proteins, red blood cells, nitrites, acidity, and specific weight and volume from a person’s urine, while in motion to detect or predict conditions such as kidney stones, urinary tract infections, hydration, pregnancy, ketone, glucose, specific gravity, cardiac failures, and other health diseases in real-time.

Current Investors

Amgen Ventures, Geberit International AG, Mekorot Water

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Monitoring Equipment, Diagnostic Equipment

Website

www.olive.earth

Verticals

HealthTech, Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.